Skip to content
DataLookout
Start free
Menu

PHAE-PHCCNCT07326189

Preoperative Right Hepatic Artery Embolization for Locally Advanced Bismuth IIIb and IV Perihilar Cholangiocarcinoma

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Recruitment opened Show 4 more changesShow less
    • Eligibility criteria expanded, about 16 words
    • Study sites: 0 to 1
    • Secondary endpoints: details revised at 1 of 5 entries
    • Publications: details revised at 6 of 6 entries
  2. Study Status, Eligibilityv2
  3. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

1-Year Overall Survival
Timeframe: 1 year post-surgery

Secondary (5)

Surgical Conversion Rate
R0 Rate
1-Year and 3-Year Recurrence-Free Survival Rate
3-Year Overall Survival
Incidence of Major Complications (Clavien-Dindo ≥ Grade III)

Arms and interventions

Preoperative Right Hepatic Artery Embolization + SurgeryExperimental

Participants receive preoperative selective embolization of the tumor-involved right hepatic artery, followed 2-4 weeks later by radical left hepatectomy or left trisectionectomy with resection of the involved artery without reconstruction.

Procedures: Preoperative Right Hepatic Artery Embolization

Sites

1 site in 1 country

  • Sun Yat-sen Memorial Hospital, Sun Yat-sen UniversityGuangzhou, Guangdong, China